Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Roche-FDA-Grants-Priority-Review-for-Genentech-s-Gazyva-in-Previously-Untreated-Follicular-Lymph-25014116/?utm_source=whatsapp&utm_medium=social&utm_campaign=share